News

JPK reports the exploration of living cells using nanoscale and single molecule techniques through the application of scanning probe microscopy.

The effort to secure a stable, domestic source of a critical medical isotope reached an important milestone this month as scientists demonstrated the production, separation and purification of molybdenum-99 (Mo-99.

Mylan has agreed to co-develop the Pulmatrix clinical-stage drug candidate PUR0200, a once-daily treatment under study for chronic obstructive pulmonary disease (COPD), outside the U.S.

A recent meta-analysis of six such clinical trials shows that behavior can have a serious impact on the effectiveness of a treatment and that the currently used DBRCT procedures may not be able to assess the effects of behavior on the treatment.

Patients will soon benefit from a unique invention, with emergency pain killer Penthrox receiving initial regulatory approval for sale in the European and UK markets.

Avalon Ventures today announced the launch of three new companies formed through its ongoing successful collaboration with GSK to fund and launch up to 10 early-stage life science companies.

Australian scientists have developed a protective seashell-inspired capsule to preserve the active biological ingredients needed to create new drugs.

Clinicians at LMU have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases.

Cardiff University researchers new discovery could have wide-reaching implications for the creation of manufactured goods, biofuels and therapeutic drugs.

For its fourth edition, the show welcomes a whole host of first time exhibitors, launches an educational theatre and introduces an exciting new feature.